As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a bit of a mixed bag. GlaxoSmithkline (GSK) saw the lagest increase, but…
According to Reuters, Microsoft (MSFT) will alter its Vista operating system so that it works better with Google (GOOG) and other companies that have search functions for the desktop. Reuters writes that…
(ALTH) Allos Therapeutics trading down 20% after its Phase III study of Efaproxyn failed to meet primary endpoint of improvement in overall survival.(BAY) Bayer raised guidance on Schering integration.(BMY) Bristol-Myers: FDA Grants…
Some sectors showed mixed results in the short selling, but the Big Pharma and medical instruments and related companies saw an increased activity in short selling in May versus April. Below is…
